NCT07317388 Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders
| NCT ID | NCT07317388 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de Ville-Evrard, France |
| Condition | Psychiatric Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 24 participants in total. It began in 2025-05-01 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effectiveness of group psychoeducation for users and carers to help people with severe psychiatric disorders achieve autonomy at home.
Eligibility Criteria
Inclusion Criteria: * Volunteer for a home autonomy project * Management of a mental health problem (mood disorder or psychotic disorder) * Consent for participation (non-opposition) * Taken care by the RPS 93 platform Exclusion Criteria: * Acute clinical state
Contact & Investigator
Raluca ROSETTI, Docrorat d'Etat en Médecine
PRINCIPAL INVESTIGATOR
EPS VILLE EVRARD
Frequently Asked Questions
Who can join the NCT07317388 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychiatric Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07317388 currently recruiting?
Yes, NCT07317388 is actively recruiting participants. Contact the research team at y.bencherif@epsve.fr for enrollment information.
Where is the NCT07317388 trial being conducted?
This trial is being conducted at Neuilly-sur-Marne, France.
Who is sponsoring the NCT07317388 clinical trial?
NCT07317388 is sponsored by Centre hospitalier de Ville-Evrard, France. The principal investigator is Raluca ROSETTI, Docrorat d'Etat en Médecine at EPS VILLE EVRARD. The trial plans to enroll 24 participants.